Bombesin Receptor Subtype 3 as a Potential Target for Obesity and Diabetes

Expert Opinion on Therapeutic Targets - United Kingdom
doi 10.1517/14728222.2015.1056154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target

Clinical Cancer Research
Cancer ResearchOncology
2016English

Galectin-3 as a Potential Target to Prevent Cancer Metastasis

Clinical Medicine Insights: Oncology
Oncology
2015English

Adipose ABCG1: A Potential Therapeutic Target in Obesity?

Adipocyte
HistologyCell Biology
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

RIC-3, a Potential Target for Regulating Cholinergic Signaling and Inflammation

Journal of Immunological Sciences
2017English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Systolic Blood Pressure as a Potential Target of Sigma-1 Receptor Agonist Therapy

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Discoidin Domain Receptor 2 as a Potential Therapeutic Target for Development of Disease-Modifying Osteoarthritis Drugs

American Journal of Pathology
Forensic MedicinePathology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy